Market Overview:
The global x-ray contrast agents market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in the field of medical imaging. Based on type, the medical barium sulfate segment is expected to account for the largest share of the global x-ray contrast agents market in 2018. This segment is also projected to grow at a CAGR of 5.9% from 2018 to 2030. The iodine segment is projected to grow at a CAGR of 6% during this period. Based on application, hospitals are expected to account for the largest share of the global x-ray contrast agents market in 2018 followed by clinics.
Product Definition:
X-ray contrast agents are substances used to improve the visibility of organs or tissues on an X-ray image. Contrast agents work by altering the way that x-rays scatter when they pass through tissues. This alteration allows for improved visualization of certain structures within the body. Contrast agents are typically administered intravenously, and can be used to improve images of a variety of organs, including the brain, heart, and kidneys.
Medical Barium Sulfate:
Medical barium sulfate is a radiographic contrast agent used in medical imaging. It has high molecular weight and low solubility in water, which makes it suitable for use as an X-ray contrast media. The product is administered intravenously to the patient and then filtered into the blood system where it mixes with blood cells to form a black colored solution that can be seen on x-ray images taken of the body parts.
Iodine:
Iodine is a chemical element that is found in the soil, water, and air. It has a bright yellow color with a slight bluish tint. Iodine can be obtained from several sources including potassium iodide, fossil fuel-rich dirt/waste products (uranium), and by using electricity as an energy source (iodized salt).
Application Insights:
Based on application, the global x-ray contrast agents market is segmented into hospitals, clinics and other. Hospitals held the largest share in 2017 owing to factors such as a high usage rate of these agents for diagnostic imaging procedures. Furthermore, increasing investments by governments in healthcare infrastructure development are expected to further propel growth over the forecast period.
The clinics and other application segment is anticipated to witness significant growth during the forecast period due to rising demand for advanced diagnostics techniques that provide better accuracy compared with conventional methods used in medical imaging. Moreover, increasing R&D activities pertaining to new generation Contrast Media I which have higher specificity & sensitivity than Medical Barium X-rays will boost industry growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technology and increasing prevalence of cancer & other diseases. Moreover, availability of reimbursement facilities for medical treatments offered by hospitals is also expected to drive the demand for contrast agents in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising geriatric population and awareness about various treatment options available for various diseases. In addition, growing medical tourism industry in emerging economies such as India & China are expected boost product demand during the forecast period. Availability of a large patient pool suffering from chronic disorders such as diabetes & kidney stones also drives regional growth.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the increasing preference for minimally invasive procedures over traditional open surgery, which leads to shorter hospital stays, faster recoveries, and reduced pain and scarring. The use of X-ray contrast agents helps in better visualization of tissues and organs during these procedures, thereby aiding in more accurate diagnoses and improved surgical outcomes.
- Rising incidence of cancer: According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for 8 million deaths per year. The number of new cases is expected to rise by 70% over the next two decades due to population growth and aging trends. X-ray contrast agents are used extensively in diagnostic imaging for cancer detection and treatment planning purposes. As such, rising incidence rates will lead to increased demand for these agents in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
X-Ray Contrast Agents Market Research Report
By Type
Medical Barium Sulfate, Iodine
By Application
Hospitals, Clinics, Other
By Companies
Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global X-Ray Contrast Agents Market Report Segments:
The global X-Ray Contrast Agents market is segmented on the basis of:
Types
Medical Barium Sulfate, Iodine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lantheus Medical Imaging
- Bracco SpA
- GE Healthcare
- Daiichi Sankyo Company
- Bayer
- Guerbet Group
- Hengrui Medicine
- BeiLu Pharmaceutical
Highlights of The X-Ray Contrast Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Barium Sulfate
- Iodine
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the X-Ray Contrast Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
X-Ray contrast agents are a type of medication that help doctors see inside the body. They work by making tissues and organs appear brighter on an x-ray image than they would without the agent.
Some of the key players operating in the x-ray contrast agents market are Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical.
The x-ray contrast agents market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 X-Ray Contrast Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 X-Ray Contrast Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 X-Ray Contrast Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the X-Ray Contrast Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global X-Ray Contrast Agents Market Size & Forecast, 2018-2028
4.5.1 X-Ray Contrast Agents Market Size and Y-o-Y Growth
4.5.2 X-Ray Contrast Agents Market Absolute $ Opportunity
Chapter 5 Global X-Ray Contrast Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 X-Ray Contrast Agents Market Size Forecast by Type
5.2.1 Medical Barium Sulfate
5.2.2 Iodine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global X-Ray Contrast Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 X-Ray Contrast Agents Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global X-Ray Contrast Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 X-Ray Contrast Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America X-Ray Contrast Agents Analysis and Forecast
9.1 Introduction
9.2 North America X-Ray Contrast Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America X-Ray Contrast Agents Market Size Forecast by Type
9.6.1 Medical Barium Sulfate
9.6.2 Iodine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America X-Ray Contrast Agents Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe X-Ray Contrast Agents Analysis and Forecast
10.1 Introduction
10.2 Europe X-Ray Contrast Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe X-Ray Contrast Agents Market Size Forecast by Type
10.6.1 Medical Barium Sulfate
10.6.2 Iodine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe X-Ray Contrast Agents Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific X-Ray Contrast Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific X-Ray Contrast Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific X-Ray Contrast Agents Market Size Forecast by Type
11.6.1 Medical Barium Sulfate
11.6.2 Iodine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific X-Ray Contrast Agents Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America X-Ray Contrast Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America X-Ray Contrast Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America X-Ray Contrast Agents Market Size Forecast by Type
12.6.1 Medical Barium Sulfate
12.6.2 Iodine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America X-Ray Contrast Agents Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) X-Ray Contrast Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) X-Ray Contrast Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) X-Ray Contrast Agents Market Size Forecast by Type
13.6.1 Medical Barium Sulfate
13.6.2 Iodine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) X-Ray Contrast Agents Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 X-Ray Contrast Agents Market: Competitive Dashboard
14.2 Global X-Ray Contrast Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lantheus Medical Imaging
14.3.2 Bracco SpA
14.3.3 GE Healthcare
14.3.4 Daiichi Sankyo Company
14.3.5 Bayer
14.3.6 Guerbet Group
14.3.7 Hengrui Medicine
14.3.8 BeiLu Pharmaceutical
